CHICAGO, Aug. 13, 2024 /PRNewswire/ -- The
global Intracardiac Echocardiography (ICE) Market is expected
to grow from USD 333 million in 2024
to USD 545 million by 2029, at a CAGR
of 10.3%. The intracardiac echocardiography (ICE) market is
influenced by factors such as an aging population, rising heart
failure rates, and advancements in imaging technologies. While the
demand for ICE is expected to grow due to improved integration with
other imaging techniques and predictive algorithms, challenges like
high product costs and technical constraints may limit its
expansion. Traditional ICE devices offer heart defect visualization
via ultrasound, but newer techniques are emerging, potentially
replacing transesophageal echocardiogram (TEE) devices with
advanced technology that enhances diagnostic accuracy and data
management. Opportunities in the market include advancements in
real-time and 3D imaging, though high costs and technical
limitations remain significant barriers. Major players include GE
Healthcare, Medtronic, Philips Healthcare, and Siemens
Healthineers, with Asia-Pacific
projected to experience the highest growth due to economic
development and increased healthcare services.
![MarketsandMarkets Logo MarketsandMarkets Logo](https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg)
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95683005
Browse in-depth TOC on "Intracardiac Echocardiography
(ICE) Market"
261 - Tables
56 - Figures
297 -
Pages
Abbott Laboratories: Leading Provider of Intracardiac
Echocardiography Technologies
Abbott Laboratories (US) is a key player in intracardiac
echocardiography (ICE), offering advanced solutions such as the
ViewFlex Xtra ICE Catheter and the ViewMate Ultrasound Console.
These technologies provide real-time, high-resolution visualization
of cardiac structures, essential for guiding various interventional
treatments, from catheter ablations to electrophysiological tests.
The ViewMate Ultrasound Console supports precise cardiac treatment
by delivering detailed images, potentially reducing the need for
more invasive procedures and improving safety and effectiveness in
modern cardiology.
GE Healthcare: Innovator in Cardiovascular Ultrasound
Solutions
GE Healthcare (US) is a leader in ICE technology, known for its
Vivid series cardiovascular ultrasound devices. The Vivid Ultra
Edition enhances clinical efficiency with superior image quality,
advanced visualization, and workflow automation. The Vivid S
Series, celebrated for its portability and ease of use, is
complemented by AI-enhanced Venue Ultrasound Systems, which
automate cardiac imaging and streamline diagnostics. GE
Healthcare's ICE systems provide cardiologists with advanced
imaging options, enhancing clinical judgment and patient care.
Medtronic plc: Key Contributor to ICE Technology
Medtronic plc (Ireland) is a
prominent provider of ICE technology, known for its high-resolution
cardiac imaging and interventional support. The company's steerable
sheath, FlexCath, and the ViewFlex ICE catheter, originally
developed by St. Jude Medical, are critical for precise navigation
during procedures. Medtronic's ICE technology is particularly
valuable for atrial fibrillation ablation, offering real-time
imaging to improve accuracy and results, and guiding clinicians
with comprehensive safety protocols.
Philips Healthcare: Leader in 3D Intracardiac
Echocardiography
Philips Healthcare (Netherlands) excels in ICE technology with its
advanced 3D ICE catheters, including the VeriSight Pro. This
state-of-the-art 9 French system with an 840-element matrix array
provides real-time 3D imaging, enhancing the precision of minimally
invasive cardiac procedures. Recent expansions, such as the
VeriSight Pro's introduction in Hong
Kong, aim to offer cutting-edge tools to medical
professionals, improving patient outcomes and procedural
accuracy.
Siemens Healthineers: Pioneer in ICE Imaging
Siemens Healthineers (Germany)
is renowned for its innovations in ICE technology, offering
high-resolution imaging that enhances cardiac care. The ACUSON P500
ICE System is part of Siemens' extensive portfolio, providing
accurate anatomical visualization that boosts procedural efficiency
and patient outcomes. Siemens Healthineers' ICE solutions continue
to set new standards in cardiac imaging with their comprehensive,
real-time visualizations, contributing significantly to the field
of cardiology.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=95683005
Product Segment: ICE Ultrasound Systems with Built-In
Software Leads
The intracardiac echocardiography (ICE) market is segmented into
ICE Catheters (including Doppler, phased-array, fixed-array, and
mechanical rotational types), ICE Ultrasound Systems with Built-In
Software Applications (such as 2D, 3D/4D, and Doppler ultrasound
systems), disposable accessories, ICE Consoles (cart/trolley-based
and hand-held/portable), guiding catheters and sheaths, and
software. The segment for ICE Ultrasound Systems with built-in
software applications holds the largest market share. This
dominance is attributed to the growing preference for minimally
invasive cardiac procedures, which ICE supports by providing
real-time, high-resolution imaging that aids in accurate guidance
during interventions. Technological advancements in ultrasound
transducers and catheter design have enhanced the accuracy and
safety of cardiac procedures, particularly when combined with other
imaging modalities. However, challenges remain in deploying ICE in
resource-limited healthcare settings due to issues with spatial
precision, the need for specialized operator skills, and high
costs.
Application Segment: Electrophysiology Takes the Lead
The ICE market applications include cardiac monitoring,
structural heart defects, electrophysiology, left atrial appendage
closure, and other uses. Electrophysiology led the market in 2023
due to its benefits in providing superior visualization of blood
flow and high-resolution imaging of cardiac structures, which
improves safety during cardiac procedures. ICE technology
facilitates serial monitoring of cardiac conditions, aiding in
effective management of chronic heart conditions and long-term
surveillance of cardiac health.
End User Segment: Hospitals & Surgical Centers
Dominate
The ICE market is categorized into hospitals & surgical
centers (diagnostic), ambulatory surgical centers (ASCs),
hospital-based cath labs/hybrid or interventional centers,
independent diagnostic centers, and other end users. In 2023,
hospitals and surgical centers with diagnostic capabilities
accounted for the largest share. This is due to benefits such as
reduced hospital stays and recovery times, enhanced clinical
utility of imaging technology, and increasing demand for complex
diagnostic services, prompting hospitals and surgical centers to
expand their diagnostic offerings.
Regional Insights: North America Leads the Market
The ICE market is divided into North
America, Europe,
Asia Pacific, Latin America, and the Middle East and Africa. North
America emerged as the dominant region in 2023, holding the
largest market share. This is driven by a growing elderly
population prone to cardiac issues, advanced healthcare
infrastructure, and high healthcare expenditure. North America's integration of modern
diagnostic technologies like ICE supports enhanced imaging
capabilities, improving the visualization of cardiac structures and
blood flow. These factors contribute to a robust and expanding ICE
market in the region.
For more information, inquire now! Inquire Now
Related Reports:
Diagnostic Imaging Market
Ultrasound Market
Diagnostic Imaging Services Market
Surgical Imaging Market
Intraoperative Imaging Market
Get access to the latest updates on Intracardiac
Echocardiography Companies and Intracardiac
Echocardiography Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/intracardiac-echocardiography-ice-market-worth-545-million-by-2029-driven-by-technological-advancements--marketsandmarkets-302220688.html